Advanced glycation end products and the progressive course of renal disease
- 1 October 2001
- journal article
- review article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 38 (4) , S100-S106
- https://doi.org/10.1053/ajkd.2001.27414
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Advanced glycation end products (AGEs)‐induced expression of TGF‐β1 is suppressed by a protease in the tubule cell line LLC‐PK1Nephrology Dialysis Transplantation, 2001
- Importance of oxidatively modified proteins in chronic renal failureKidney International, 2001
- Differences in the modulating potential of advanced glycation end product (AGE) peptides versus AGE proteinsKidney International, 2001
- Differences in the modulating potential of advanced glycation end product (AGE) peptides versus AGE proteinsKidney International, 2001
- Nitric oxide inhibits the formation of advanced glycation end productsKidney International, 2000
- Amadorins: Novel Post-Amadori Inhibitors of Advanced Glycation ReactionsBiochemical and Biophysical Research Communications, 1999
- Immunocytochemical detection of advanced glycated end products in rat renal tissue as a function of age and diabetesKidney International, 1998
- Progression of nephropathy in spontaneous diabetic rats is prevented by OPB-9195, a novel inhibitor of advanced glycationDiabetes, 1997
- Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failureThe Lancet, 1994
- Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic ComplicationsNew England Journal of Medicine, 1988